Budesonide/Formoterol Fumarate
Brand name: Symbicort
Rank #22 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$759.4M
Total Cost
1,452,561
Total Claims
$759.4M
Total Cost
45,441
Prescribers
$523
Cost per Claim
223,970
Beneficiaries
1,984,484
30-Day Fills
$17K
Avg Cost/Provider
32
Avg Claims/Provider
Share of Medicare Part D Spending
0.28%
of total Medicare Part D spending
$759.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $759.4M total
🔎 Data Overview
Ranked #22 out of 500 drugs tracked by total cost. Budesonide/Formoterol Fumarate represents a significant portion of Medicare drug spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Budesonide/Formoterol Fumarate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Jorge Sanchez-Masiques | Pulmonary Disease | Miami, FL | 5,055 | $2.1M |
| 2 | Jahaira Serrano Dominguez | Pulmonary Disease | Arecibo, PR | 2,361 | $925K |
| 3 | Jorge Sanchez-Masiques | Pulmonary Disease | Miami, FL | 2,961 | $790K |
| 4 | Mohammad-Ali El-Harakeh | Internal Medicine | Prescott, AZ | 831 | $536K |
| 5 | Vishnu Patel | Internal Medicine | Princeton, WV | 868 | $441K |
| 6 | Jason Karp | Pulmonary Disease | Lake Success, NY | 517 | $385K |
| 7 | Venkata Dodda | Pulmonary Disease | Bloomington, IL | 510 | $374K |
| 8 | Fateh Ahmed | Pulmonary Disease | Toledo, OH | 654 | $374K |
| 9 | George Martin | Allergy/ Immunology | Wynnewood, PA | 507 | $368K |
| 10 | Richard Deluca | Pulmonary Disease | Bronx, NY | 448 | $355K |
| 11 | Bradley Chipps | Pulmonary Disease | Sacramento, CA | 514 | $342K |
| 12 | Jon Michel | Pulmonary Disease | Peoria, IL | 571 | $331K |
| 13 | Mohammad Chaudhry | Internal Medicine | Union City, NJ | 689 | $328K |
| 14 | Ernesto Mejia | Pulmonary Disease | Morristown, TN | 554 | $317K |
| 15 | Hazen Tuck | Pulmonary Disease | Janesville, WI | 568 | $309K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 19 | Ustekinumab (Stelara) | $852.3M | 31,974 |
| 20 | Paliperidone Palmitate (Invega Sustenna) | $832.3M | 252,388 |
| 21 | Insulin Aspart (Novolog Flexpen) | $831.6M | 958,823 |
| 22 | Budesonide/Formoterol Fumarate (Symbicort) | $759.4M | 1,452,561 |
| 23 | Palbociclib (Ibrance) | $755.1M | 48,329 |
| 24 | Nintedanib Esylate (Ofev) | $703.7M | 53,928 |
| 25 | Ruxolitinib Phosphate (Jakafi) | $698.1M | 46,655 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology